HHS establishes Office of Consumer Information and Insurance Oversight, headed by former Missouri insurance commissioner Jay Angoff, to manage private insurance reforms under health reform law.
Genentech gets warning letter over promotion for chemo drug Rituxan (rituximab) citing the company for using as referrence inadequate clinical trial evidence.
In rejecting Teva's citizen petition to block approval of generic versions of Copaxone, FDA says it has not yet determined the criteria for establishing whether the active ingredient in generic Copaxone is the "same as" that in the brand name drug. FDA said a finding of sameness does not require a finding of "complete chemical identity."
